Skip to main content

Carpenter Technology

MaterialsPhiladelphia, USA· One of 924 Materials companies tracked by AMPulse

Carpenter Technology Corporation produces specialty alloys including titanium, stainless steels, alloy steels, tool steels, and metal powders for additive manufacturing, served through its Carpenter Additive business unit.

CEO / Founder
Tony R. Thene
Team Size
4,600
Stage
Active
Total Funding
Publicly Traded
Latest Round
Undisclosed
Key Investors
BlackRock, The Vanguard Group, Dimensional Fund Advisors

Technology & Products

Key Products

["Titanium alloys","Stainless steels","Alloy steels","Tool steels","Metal powders for additive manufacturing","Powder lifecycle management (PowderLife)"]

Technological Advantage

End-to-end additive manufacturing ecosystem including powder production, part manufacturing, and powder lifecycle management, enabling highly customized and reliable solutions.

Differentiation

Value Proposition

High-performance specialty alloys and comprehensive additive manufacturing material solutions from powder production through to finished parts, enabling mission-critical applications.

How They Differentiate

Deep legacy in specialty alloys with an integrated metal additive manufacturing offering from powder to finished parts, contrasting competitors who focus on segments of the AM process.

Market & Competition

Target Customers

Aerospace, defense, transportation, energy, industrial, medical, and consumer electronics companies.

Industry Verticals

["Aerospace","Defense","Transportation","Energy","Industrial","Medical","Consumer Electronics"]

Competitors

Sandvik; GKN Additive; Oerlikon

Growth & Milestones

Growth Metrics

Reported $2.55 billion revenue in 2023, a 38.88% increase from 2022.

Major Milestones

["1889: Founded as Carpenter Steel Company","1992: Patented super-strong Aermet alloy","2018: Acquired LPW Technology","2019: Launched Carpenter Additive business unit","2019: Opened Emerging Technology Center in Alabama"]

Notable Customers

Aerospace, defense, and medical industry leaders (specific names not publicly disclosed).